Pfizer (NYSE:PFE) has seen a notable increase in options activity, with a bearish sentiment prevailing among investors. Analysis of 27 trades reveals 29% bullish and 59% bearish positions, with significant activity in puts and calls indicating a price band focus between $15.0 and $32.5. The market's attention on Pfizer's options suggests liquidity and interest at these strike prices. Pfizer, a leading pharmaceutical company with annual sales nearing $50 billion, has its stock price currently up 1.15% at $28.17. Analyst ratings over the past month average a target price of $38.75, with varying opinions from firms like Cantor Fitzgerald and Morgan Stanley.